25 cases of neurologic complications of influenza were reported from Great Britain beginning in 2011. 84% of cases were seen in children. A variety of distinct neurological manifestations were seen. 80% of patients required intensive care, 68% had poor outcomes, and 4 patients (16%) died.
On March 21, 2014, two new antibiotics with activity against methicillin-resistant Staphylococcus aureus (MRSA) each received unanimous recommendations from FDA Advisory Committees for approval for treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive organisms.